组织库市场规模、份额和成长分析（按应用、最终用途和地区划分）－2026-2033年产业预测

预计到 2024 年，全球组织库市场规模将达到 45.3 亿美元，到 2025 年将达到 47.7 亿美元，到 2033 年将达到 72.1 亿美元，预测期（2026-2033 年）的复合年增长率为 5.3%。

由于心血管疾病、糖尿病和癌症等慢性疾病的日益普遍，以及创伤和严重烧烫伤病例的增加导致移植手术数量激增，全球组织库市场正经历显着增长。这种需求的激增推动了对心臟瓣膜、角膜、皮肤移植片和骨碎片等重要人体组织供应的进一步需求，促使医疗机构和政府对组织库基础设施进行大规模投资。冷冻保存和玻璃化冷冻等保存技术的进步提高了保存组织的活性和安全性，降低了污染和劣化的风险，并延长了其保质期。因此，医疗机构更愿意在复杂的手术中使用保存的组织，从而改善患者的治疗效果，并扩大组织库在全球的应用。

全球组织库市场按应用程式、组织库类型、最终用途和地区进行细分。依应用划分，可分为再生医学、药物研发、组织工程及移植。依组织库类型划分，可分为细胞库、器官库、组织库三个部分。依最终用途划分，可分为医院、研究机构和製药公司。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

全球组织库市场驱动因素

人们对再生医学日益增长的兴趣正在推动全球组织库市场的扩张。随着干细胞疗法、组织移植和个人化医疗需求的不断增长，组织库已成为供应关键生物材料的重要管道。这种不断增长的需求促进了组织保存技术的进步和全球生物银行基础设施的建设。因此，组织库产业预计将迎来显着成长，在满足研究人员和医疗专业人员需求的同时，也为依赖高品质生物样本的创新医疗解决方案的发展做出贡献。

全球组织库市场面临的限制因素

全球组织库市场的发展面临许多挑战，其中涉及组织捐赠、知情同意流程和隐私问题等伦理和法律的考量尤其突出。各国严格的监管规定和法律体制的差异进一步加剧了这些复杂性，使得组织库难以确保营运实务的一致性。此外，不同地区不同的伦理标准也增加了组织采集和使用的复杂性，最终阻碍了组织库在市场中有效运作和拓展服务的能力。

全球组织库市场趋势

全球组织库市场正呈现日益显着的趋势，即越来越多地采用自动化生物银行系统。这些系统显着提高了组织采集、储存和分析的操作效率和准确性。透过最大限度地减少人为错误并优化检体保存，这些先进技术正在推动生物银行流程的创新发展。这种转变不仅提高了营运效率，也满足了科学研究和临床应用对高品质生物检体日益增长的需求。因此，自动化技术的整合正成为组织库发展的关键要素，促进了相关技术的进步，从而满足医疗保健领域的研究和商业性需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 顾客购买行为分析

全球组织库市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
• 冷冻保存装置
• 解冻装置
• 品管设备
• 其他的

全球组织库市场规模（依组织类型划分）及复合年增长率（2026-2033 年）

• 心臟瓣膜
• 角膜
• 脑和脊髓
• 骨骼和皮肤

全球组织库市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 治疗
• 化妆品
• 研究与开发
• 药物发现

全球组织库市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 生物样本库
• 医院和诊所
• 研究和学术机构
• 其他的

全球组织库市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.（US）
• Sigma-Aldrich Co.（US）
• BioLifeSolutions（US）
• Core dynamics GmbH（US）
• Taylor-Wharton（US）
• Panasonic Holdings Corporation（Japan）
• QIAGEN（Germany）
• VWR International, LLC（US）
• Danaher（US）
• Tecan Trading AG（Switzerland）
• Brooks Automation, Inc.（US）

结论与建议

Global Tissue Banking Market size was valued at USD 4.53 Billion in 2024 poised to grow from USD 4.77 Billion in 2025 to USD 7.21 Billion by 2033, growing at a CAGR of 5.3% in the forecast period (2026-2033).

The global tissue banking market is experiencing substantial growth due to the rising prevalence of chronic diseases, such as cardiovascular issues, diabetes, and cancer, along with increased cases of trauma and severe burns, which have led to more transplant surgeries. This surge necessitates a greater supply of essential human tissues, including heart valves, corneas, skin grafts, and bone segments, prompting significant investments from healthcare institutions and governments in tissue banking infrastructure. Advances in preservation techniques like cryopreservation and vitrification enhance the viability and safety of stored tissues, mitigating contamination and degradation risks while extending shelf life. Consequently, healthcare providers are more inclined to use banked tissues in complex procedures, leading to improved patient outcomes and broadening the applications of tissue banks worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Banking Market Segments Analysis

The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.

Driver of the Global Tissue Banking Market

The increasing interest in regenerative medicine plays a crucial role in the expansion of the global tissue banking market. As the necessity for stem cell therapies, tissue transplants, and customized medical treatments rises, tissue banks become essential in supplying vital biological materials. This heightened demand catalyzes advancements in tissue preservation technologies and the development of biobanking infrastructure on a worldwide scale. As a result, the tissue banking sector is poised for significant growth, addressing the needs of researchers and healthcare professionals while contributing to the advancement of innovative medical solutions that rely on quality biological samples.

Restraints in the Global Tissue Banking Market

The growth of the global tissue banking market faces significant challenges due to ethical and legal concerns related to tissue donation, consent processes, and privacy issues. These complexities are exacerbated by strict regulations and the diverse legal frameworks that exist in different countries, making it difficult for tissue banks to ensure consistent operational practices. Furthermore, the need to comply with varying local ethical standards adds layers of complexity to tissue collection and utilization, which ultimately hampers the ability of tissue banks to operate efficiently and expand their services within the marketplace.

Market Trends of the Global Tissue Banking Market

The global tissue banking market is experiencing a notable trend towards the increased adoption of automated biobanking systems, which significantly enhance the operational efficiency and accuracy of tissue collection, storage, and analysis. By minimizing human error and optimizing sample preservation, these advanced technologies are facilitating innovative approaches in biobanking processes. This shift not only streamlines operations but also aligns with the growing demand for high-quality biological samples in research and clinical applications. Consequently, the integration of automation is becoming a pivotal factor in the evolution of tissue banking, fostering advancements that cater to both scientific and commercial needs in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Customer Buying Behavior Analysis

Global Tissue Banking Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
• Cryopreservation Equipment
• Thawing Equipment
• Quality Control Equipment
• Others

Global Tissue Banking Market Size by Tissue Type & CAGR (2026-2033)

• Market Overview
• Heart Valves
• Cornea
• Brain and Spinal Cord
• Bone and Skin

Global Tissue Banking Market Size by Application & CAGR (2026-2033)

• Market Overview
• Therapeutic
• Cosmetic
• Research and Development
• Drug Discovery

Global Tissue Banking Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Biobanks
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Global Tissue Banking Market Size & CAGR (2026-2033)

• North America (Product, Tissue Type, Application, End-User)
  • US
  • Canada
• Europe (Product, Tissue Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Tissue Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Tissue Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Tissue Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Co. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLifeSolutions (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Core dynamics GmbH (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taylor-Wharton (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panasonic Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VWR International, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Trading AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brooks Automation, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations